Updated Review Confirms Potential Risk of Bladder Cancer with Pioglitazone.
Diane S. Aschenbrenner is an assistant professor at Notre Dame of Maryland University in Baltimore. She also coordinates Drug Watch: daschenbrenner@ndm.edu.
Diane S
DS
Aschenbrenner
D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy; D006801:Humans; D007004:Hypoglycemic Agents / Q000009:adverse effects*; D000077205:Pioglitazone; D012306:Risk; D045162:Thiazolidinediones / Q000009:adverse effects*; D001749:Urinary Bladder Neoplasms / Q000139:chemically induced*
D007004:Hypoglycemic Agents; D045162:Thiazolidinediones; D000077205:Pioglitazone